Introduction
============

Role of Health-Based Payment Models
-----------------------------------

Since 1985, HCFA has made capitated payments to managed care organizations that enroll Medicare beneficiaries. HCFA, using a demographic risk adjuster to calculate payments equal to 95 percent of what health maintenance organization (HMO) enrollees "would have cost" had they remained in the traditional fee-for-service Medicare program, paid less-than-average dollars for the group who originally transferred into these programs. However, HCFA still appears (on average) to have overpaid, because the early switchers into Medicare managed care were healthier than comparably aged non-switchers ([@b5-hcfr-21-3-007]). Anticipating and responding to this problem, HCFA has sponsored much research, including development of the Diagnostic Cost Group (DCG) models, with the goal of being able to better match HMO payments to the health care needs of enrollees. Since 1984, when researchers at Boston University and Brandeis initiated this work for HCFA, DCGs have evolved into a family of methods for using administrative data collected during patient encounters to calculate health-based "expected costs" for populations ([@b1-hcfr-21-3-007], [@b2-hcfr-21-3-007], [@b4-hcfr-21-3-007]; [@b6-hcfr-21-3-007]; [@b7-hcfr-21-3-007], [@b8-hcfr-21-3-007]; [@b15-hcfr-21-3-007], [@b16-hcfr-21-3-007], [@b17-hcfr-21-3-007]).

DCG models use age, sex, and diagnoses generated from patient encounters with the medical delivery system to infer which medical problems are present for each individual and their likely effect on health care costs for a population. Some versions of the DCG models focus on diagnoses that form the principal reason for an inpatient admission, now called "PIP diagnoses" ([@b2-hcfr-21-3-007]; [@b6-hcfr-21-3-007]; [@b17-hcfr-21-3-007]). Other versions, such as the DCG/HCC models of this article, utilize the full range of diagnoses generated during all face-to-face encounters with clinicians ([@b7-hcfr-21-3-007], [@b8-hcfr-21-3-007]; [@b3-hcfr-21-3-007]; [@b15-hcfr-21-3-007]). Whereas previous publications using DCGs have calibrated models solely for Medicare samples, in this study, we contrast the ability of DCG/HCC models to predict resources in three different samples: privately insured, Medicaid, and Medicare.

Payment methods establish incentives. For example, when payments follow a "piecework" model, as in traditional fee-for-service medicine, providers are rewarded for doing more---whether the additional utilization is valuable or not. Conversely, capitated payments encourage doing less---whether through efficiency or stinting. Further, flat-rate capitated payments introduce a new perverse incentive: to enroll healthy people and to do the very little required to keep them enrolled. Models that pay each person\'s expected cost eliminate the incentive to "select on risk" and make efficiency the main way for a plan to achieve a competitive advantage ([@b19-hcfr-21-3-007]).

Although risk-adjusted payment solves the problem of perverse patient-selection incentives, linking payments to a risk-adjustment model may lead plans to invest unproductive effort in making their enrollees "look needier" according to that model. For example, models that pay more for health care "users" encourage both appropriate and unnecessary utilization; those that identify illness only through hospitalizations encourage admissions, and those that pay more for people with more coded illnesses encourage "diagnostic discovery." This last incentive can be good to the extent that it rewards plans that keep better track of their members\' chronic illnesses ([@b9-hcfr-21-3-007]). The degree of imperfection in incentive-setting is one criterion in choosing among payment models. Furthermore, how much imperfection is acceptable depends upon the nature and level of problems associated with available alternatives.

Predicting Costs in a Range of Populations
------------------------------------------

The original DCG models are prospective, that is, they use baseline, or year 1, data to infer the level of need for health care in year 2 and were developed to predict costs for Medicare beneficiaries. Medical conditions (diagnoses) detected in year 1 are used to organize people into groups with similar levels of future health care need. The distribution of all members by levels of future need characterizes an enrolled group and is used to determine a health-based payment. More recently, we have developed DCG models to calculate expected concurrent expenses, that is, expenses that occur in the same year as the diagnoses used to characterize the population ([@b15-hcfr-21-3-007], [@b16-hcfr-21-3-007], [@b17-hcfr-21-3-007]). We have also adapted both prospective and concurrent modeling frameworks for use in Medicaid and commercially insured (private) populations under the age of 65 ([@b3-hcfr-21-3-007]).

Concurrent models may be particularly useful for provider profiling and monitoring, because knowing all the medical problems being treated during a period of time is particularly relevant for estimating the level of resources used to treat them. However, prospective models, which predict future costs, are more appropriate for creating payments to managed care organizations that assume financial risk, because they focus on the presence of illnesses, such as cancer and heart disease, that predictably make people more expensive to treat.

In this article, we describe prospective models only, as they apply to three separate populations: a national sample of commercially insured enrollees under age 65, enrollees in Michigan\'s Medicaid program, and a national sample of Medicare beneficiaries. We refer to these three populations and the models that pertain to them as private, Medicaid, and Medicare. Continuing the tradition in which DCG models were originally developed, these models reflect concern for appropriate incentives in payments to health care plans and providers. All DCG/HCC models (regardless of the population or whether they are concurrent or prospective) rely on a common classification structure, which we describe later. Diversity across populations is handled by using different coefficients, different exclusions of potential predictors from payment models, and different constraints on coefficients across age or eligibility groups.

Model Criteria: Accuracy, Feasibility, and Incentives
-----------------------------------------------------

The DCG models strive for accurate predictions in the face of limitations on the available data and concerns about incentives. The goal is to effectively predict costs from data that should be present in any health care delivery system, while limiting the rewards for undesirable behavior with respect to either treatment or reporting.

Although our descriptive system does classify all recorded diagnoses in order to create a comprehensive picture of problems seen, concerns about incentives cause us to not model some information. For example, we do not use the number of hospitalizations to predict cost, so as to avoid disadvantaging medical care organizations that are good at treating sick people with fewer hospitalizations. Nor do we count how often a diagnosis appears. Conceptually, DCG models are designed to predict higher costs when they detect additional conditions associated with elevated costs. Based on clinical judgment and concerns about incentives, we exclude some condition categories (CCs) from contributing to predictions entirely. For example, the presence of chemotherapy is noted in the diagnostic codes, and, therefore we classify it into a CC (number 115); however, our prospective models do not pay more for it. Higher payments are based on the presence of a particular type of cancer, rather than a choice of therapy.

Methods
=======

Populations and Data
--------------------

We describe payment models for three populations whose types of health coverage span the major ways in which health care is provided in the United States today. Specifically, we use:

-   A nationally dispersed, privately insured (indemnity-covered) population of 1.4 million people in 1992 and 1993 (the private data).

-   One million individuals covered by Michigan\'s Medicaid program in 1991-1992 (Medicaid).

-   Medicare\'s 5-percent research sample from 1991 and 1992.

The outcome variable, total program costs in year 2, is defined as total covered expenses---an amount that includes copayments, deductibles, and third-party payments---in each data set. Costs for people with less than a full year of entitlement in year 2 are annualized, based on their observed cost per month; in analyses, we treat their data as "fractional observations" ([@b6-hcfr-21-3-007]). The three populations differ substantially with respect to age and sex distributions, health care costs, and hospital experience ([Table 1](#t1-hcfr-21-3-007){ref-type="table"}). In each population, most of the data are used (in a development sample) to establish the model structure and to fit coefficients, while the rest of the data (the validation sample) are used for measuring model performance. Finally, regressions based upon all the data are used to produce the model coefficients in this article.

A fourth data set, consisting of 191,877 people under age 65 in a State employee benefit program (State data), is used to further validate the private model\'s ability to discriminate costs within important subsets of a new population, as described later.

### DCG/HCC Models

The letters DCG/HCC are used to distinguish the multicondition Hierarchical Condition Category (HCC) models from the single-condition PIP-DCG model that HCFA is using to calculate payments to Medicare HMOs in the year 2000 ([@b13-hcfr-21-3-007]; [@b12-hcfr-21-3-007]; [@b10-hcfr-21-3-007]).

Each DCG model is designed to use the diagnostic codes from the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) ([@b18-hcfr-21-3-007]) on the claims that hospitals and physicians submit to payers. (For a discussion of diagnostic coding issues, refer to [@b11-hcfr-21-3-007].) Each DCG/HCC model uses the same CCs for prediction, all of which are based on diagnostic codes, rather than procedures. DCG models summarize a person\'s health from his or her CCs and estimate expected costs based on these profiles. Although DCG models reward medical-problem identification, not all CCs are or should be used to modify payments to plans. In designing DCG models, we have anticipated "DCG creep" (changes in diagnostic coding for the purpose of increasing DCG-based payments) by making the models less sensitive to expected changes. In particular, our models exclude some CCs and impose hierarchies to reduce the sensitivity of predicted costs to three things: (1) variations in coding practice; (2) intentional coding proliferation with the aim of improving provider reimbursement (gaming); and (3) inconsistent coding of less serious or vague conditions.

Diagnostic Groups (DxGROUPs)
----------------------------

With more than 15,000 codes, the distinctions created by ICD-9-CM are too fine to be used directly as a payment classification system. Therefore, we group ICD-9-CM codes into 543 categories, called "DxGROUPs," which are the building blocks of DCG/HCC models. Each DxGROUP has a two-level numerical label and a short, clinically informative text name. All DxGROUPs with the same "whole number" stem are clinically related. For example, the "4.xy" series refers to infectious diseases, with 4.01 being bacterial enteritis, 4.02 viral enteritis, 4.03 other intestinal infections, 4.04 tuberculosis, and so on.

Each recognized ICD-9-CM code maps to a unique DxGROUP; each DxGROUP encompasses diagnostic codes that describe very similar medical problems. We place in the same DxGROUP alternative codes that can be used for the medical conditions that clinicians generally think of together (such as congestive heart failure and cardiomyopathy or deep vein thrombosis and deep vein thrombosis in pregnancy) or codes for medical conditions that are not easily distinguished (such as chronic bronchitis and emphysema).

Condition Categories
--------------------

DxGROUPs are clustered in a CC when they contain medically related problems with similar expected costs. We created the 118 diagnosis-based CCs used for modeling in each population using a mix of clinical judgment and empirical cost data. The core physician panel making these judgments consisted of four internists experienced in health services research. Specialist consultants assisted in several areas including pediatrics, HIV/AIDS (human immunodeficiency virus/acquired immunodeficiency syndrome), pediatric surgery, obstetrics, and neonatology. Although we sought to create CCs with at least 500 cases in our private sample of around 1 million people, that goal is subordinated to the objective of clinical homogeneity. For a few conditions (such as mental retardation, quadriplegia, and underweight neonates), we accept significantly smaller numbers.

We eliminate logical inconsistencies in diagnostic coding that can be identified by comparing with age and sex. For example, we drop a diagnosis of uterine disorder in a male. However, we do not drop neonatal codes found in the records of non-infant females. When an infant dies shortly after birth, insurance companies sometimes do not create a separate eligibility record but rather assign the neonatal codes to the mother. Currently, two CCs are used to classify neonatal codes assigned to mothers.

The CCs are organized in broad system groups (such as four CCs for infections, eight for neoplasms, and three each for diabetes and metabolic disorders). Short names (such as Infection1, Diabetes3) denote such CC groups; numbering within a short-name series generally indicates decreasing expected costs (e.g., Neoplasm1 contains metastatic cancers, Neoplasm2 contains high-cost site-specific cancers, Neoplasm3 has moderate-cost cancers, on down to Neoplasm8, benign neoplasms).

[Table A](#t4-hcfr-21-3-007){ref-type="table"} in the Technical Note shows for each CC, its number, long name, short name and the CCs that it donimates in the model hierarchy explained in the following section. A complete list of the individual DxGROUPs indicating their organization into CCs is available at [www.dxcg.com](www.dxcg.com) under the heading "DCG Clinical Classification System in Detail." (This information can also be obtained by contacting the lead author.)

CC Hierarchies
--------------

A payment model should not be sensitive to every diagnostic code recorded because this will result in poorly specified coefficients and unstable estimates of the relative risk of populations. For example, a female who has metastatic cancer (CC 5) could also be coded with cancer in two or more specific body sites, such as the liver (CC 6) or connective and soft tissue (CC 7). She may also have been tested for other "uncertain" (CC 10) or "benign" cellular changes (CC 12). A regression model that separately assigns credit for each of these diagnoses will have confounded parameter estimates, because the costs of people with only the simpler problems get averaged in, or confounded, with costs for people with both simple and more consequential conditions. Also, such models reward most the plans that capture as many codes as can be legitimately defended in an audit---a behavior with little social value. To dampen these incentives, we use hierarchies to constrain CC assignment as follows: a person classified into a CC is not also classified into a lower ranked CC in the same hierarchy. An important feature of an HCC model is that the hierarchies are not imposed across unrelated medical problems. For example, for a female with both cancer and diabetes, hierarchies are used to retain only the "worst" evidence of each disease, but both cancer and diabetes CCs are used in predicting her costs next year.

Hierarchies are identified for each CC in the rightmost column of [Table A](#t4-hcfr-21-3-007){ref-type="table"} by indicating which CCs are dominated; dominated CCs are zeroed out for a person when a dominating CC is present.

The CC hierarchies capture both chronic and serious acute manifestations of particular disease processes, as well as their seriousness in terms of expected costs. Some hierarchies, such as neoplasm, are simple; CC 5 dominates CC 6, which dominates CC 7, all the way down to CC 12. Other hierarchies, such as gastrointestinal, are more complex, as illustrated in [Figure 1](#f1-hcfr-21-3-007){ref-type="fig"}. A person may be classified with either, or both, acute and chronic high-cost gastrointestinal problems; however, if either of these is coded, information about moderate or lower cost GI disorders is ignored.

Clinically, hierarchies reduce the sensitivity of predicted payments to the coding of less serious manifestations of the same condition; statistically, they make explanatory variables more nearly orthogonal, increasing statistical precision. Imposing hierarchies typically increases the estimated coefficients and t-ratios of serious condition categories.

Excluded Condition Categories
-----------------------------

We also exclude some CCs from the models entirely, by constraining their coefficients to be zero; the result is that the presence of that condition for an individual will not increase his or her predicted cost. Money that "disappears" from the prediction when a positive coefficient is constrained to zero is redistributed---generally reappearing as slight increments to demographic variables. Each model still accounts for the costs of treating all conditions.

The most common reason for exclusion is the a priori medical judgment that a current problem triggering this CC this year should have little effect on next-year costs. Examples are (non-melanoma) skin cancers; benign cancers; lower cost ear, nose, and throat disorders; minor injuries; and screening (for example, presence of a routine checkup).

A second reason for exclusion is that a CC does not add to expected costs (either its coefficient in our modeling sample is actually negative or it is not statistically significantly positive). Reassuringly, these are generally the same CCs clinically thought to have little effect on future costs. Excluding CCs that would subtract from the payment preserves the monotonic character of the model. To ensure that adding a code does not reduce predicted costs, each CC with a non-positive coefficient is excluded or constrained, even if it might seem that the CC should be in the model.

A final reason for exclusion is concern over "gaming," that is, a perverse health plan response to the incentives created by the model. Thus, the models do not pay for the often vague or discretionary conditions included in CCs such as moderate and other endocrine disorders (CCs 17 and 18), and lower cost mental disorders (CC 35). Such exclusions improve the models\' attractiveness for setting payments, at the cost of some loss in accuracy.

### Coefficient Constraints

Especially for conditions that are rare (such as mental retardation, ranging from mild to profound, in an employed population), unconstrained models can lead to higher payments for less serious conditions. Thus, in a few cases, we impose restrictions across sets of CCs, forcing predictions for conditions that are higher in a hierarchy to be at least as large as predictions for conditions that they dominate (as "profound mental retardation" dominates "mild mental retardation"). These restrictions avoid plans receiving higher payments for "downcoding." We also do not modify some surprisingly low-cost coefficients that appear to be real artifacts of the coverage or delivery systems to which they apply, in the sense that they capture all costs covered by the program that collected the data but do not reflect expenditures from other sources. An example of this is the relatively low cost for people with renal failure in Medicaid because Medicare is likely to be the primary payer for most of the very high treatment costs for these people.

Clinical Refinements, Including Interactions with Age
-----------------------------------------------------

The DCG classification system, originally focused on chronic conditions of the elderly, now handles distinctions for a full age and population spectrum. There are 21 DxGROUPs organized into 5 CCs for neonates (ages 0 to 1). Additional new CCs include four for the mentally retarded (common only in Medicaid), five for mental health and substance abuse, five for accidents and injuries, seven for pregnancy, and four for congenital and/or distinctly pediatric problems.

Ultimately, a single comprehensive classification system, with 543 DxGROUPs organized into 118 CCs and a common set of imposed hierarchies, is used to profile the medical problems present for any person, regardless of age, sex, or type of insurance. However, the cost consequences of a given diagnostic profile can be affected by demographics. For example, some CCs are separately priced for pediatric populations (age under 18), in the private or Medicaid populations, when clinical judgment and empirical evidence find substantial differences in utilization by age (e.g., CC 70, asthma, adds \$1,513 for adults and only \$825 for children in the private data.) The Medicare model also recognizes age/medical interactions for a few conditions (such as HIV and aplastic anemia). For people with such conditions, certain costs are associated with it in elderly persons (those age 65 or over), but additional dollars are associated with costs of care among the disabled (younger persons whose Medicare entitlement derives from disability).

Demographic Variables
---------------------

In a given year, healthy people, whether they are age 8 or 80, incur few medical expenses. However, average health care costs differ dramatically by age and somewhat by sex. Much of this is driven by differences in disease prevalence because, for example, most children 8 years of age are fully healthy, while most persons age 80 have one or more chronic conditions requiring medical attention. Some of the cost difference is attributable to differences in the nature of certain diseases (or how they are treated) in children, young adults, or seniors. Additionally, however, even among those with no medical problems this year, demographically defined subgroups, such as females of childbearing age, or the oldest old, have different average costs next year. In a prospective model, even after accounting for the medical problems present, the additional effects of age and sex on expected costs remain important.

The three models (private, Medicaid, and Medicare) recognize three key age groups: 0-17 years, 18-64 years, 65 years or over, either by allowing some distinct CC coefficients for those under as opposed to over age 18 in the younger populations or by using distinct Medicare coefficients for those 65 or over.

The private and Medicaid models contain 16 indicators that place people within same-sex, similar-age groups (ages 0-5, 6-12, 13-17, 18-24, 25-34, 35-44, 45-54, and 55-64). The Medicare model constrains coefficients among its disabled enrollees under age 65 to distinguish only ages 0-34 and 35-64; it then makes 5-year breaks between 65 and 94 years of age; the highest age category is 95 or over.

Eligibility Categories
----------------------

In addition to age and sex categories, the Medicaid model incorporates nine additional variables that distinguish among five distinct groups of enrollees: (1) the blind and disabled (11 percent); (2) those eligible because of other medical problems (8 percent); (3) pregnant women (2 percent); (4) those with poverty-related entitlement (71 percent); and (5) others (9 percent). We assign each person to one of the categories based on reason for entitlement during his or her earliest month of enrollment in year 1. Observed annual expenditures per person in year 2 averaged \$1,430 and differed substantially by category. The blind and disabled are by far the most expensive, at \$5,585 annually in year 2. Pregnant women cost about twice the average (\$2,708); the "other medical" and "other" groups are about average (\$1,281 and \$1,500, respectively) and the non-medical, poverty-related group, consisting mainly of children enrolled under Aid to Families with Dependent Children, cost about one-half the average (\$731).

Four of the new variables are indicators (yes-no variables) that distinguish Medicaid\'s other subpopulations from the least expensive, poverty-related subgroup. The remaining five additional demographic variables in the model are interactions of eligibility category and duration of (year 1) Medicaid enrollment. These variables allow the model to reflect the fact that recent entrants to the Medicaid program cost more than longer term "stayers," and that the "premium" for recent entry varies not only by duration of enrollment but by eligibility type. These five variables each have the form:
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How all this works is best illustrated with examples, as shown in the following section.

Sample Calculations of Expected Costs
-------------------------------------

Each HCC model prediction is the sum of a demographic part and a health-status part. We illustrate this in [Figure 2](#f2-hcfr-21-3-007){ref-type="fig"} for two privately insured females 58 years of age. The numbers here are private-model coefficients, shown in the first column of [Table 2](#t2-hcfr-21-3-007){ref-type="table"}. Both patients\' estimated costs begin with a demographic component of \$1,730, which is the final prediction for any fully healthy, privately insured female between the ages of 55 and 64. Each of these patients, however, also has medical conditions with expected consequences for future health care costs.

[Figure 2](#f2-hcfr-21-3-007){ref-type="fig"} shows how the model organizes each patient\'s ICD-9-CM data into a clinical profile that leads to the health-status part of her prediction. For patient 1, her breast cancer diagnosis adds \$2,372; her hypertension, a distinct medical problem, adds another \$915, for a total of \$5,017. Patient 2 has breast cancer, too, but her cancer has metastasized and is coded at multiple sites (lung, liver, and bone). Note the different ways that additional information about cancer is reflected in the classification: in one, distinct but related diagnoses are classified into the same DxGROUP; in another, related DxGROUPs are classified into the same CC; in a third, one CC is ranked higher than another. In the end, only a single payment amount (\$21,884) is calculated for metastatic cancer; any additional codes pertaining to benign or malignant neoplasms are ignored.

Another example clarifies how the Medicaid demographic/eligibility variables work. This time the numbers are drawn from the Medicaid column of [Table 2](#t2-hcfr-21-3-007){ref-type="table"}. We compute the predicted cost for a female age 20 with no medical problems and a full year 1 of poverty-related Medicaid by adding \$560 (the "female, age 18-24" base amount) to \$476 (poverty-related eligibility) for a total of \$1,036. If the female had been present for only 10 months in year 1, we add another \$112, that is, \$56 for each of the two missing year-1 months, for a total of \$1,148. If she were present for only 2 months in year 1, we would add 10×56 to \$1,036, for a total of \$1,596. In contrast, consider a female of the same age and present for 10 months in year 1 but who is eligible for Medicaid because of disability rather than poverty. We add three numbers to arrive at the demographic part of this female\'s prediction: \$560 for age and sex, \$1,449 for disability entitlement, and \$179×2 for her two missing year-1 months as a disability-entitled person. The demographic part of this female\'s expected cost next year is then \$2,367; in computing her total expected costs, dollars for the future cost implications of her year-1 medical conditions are added to \$2,367.

We include one final example to illustrate how health-status information can interact with age. Consider the payment for a Medicare-entitled male 66 years of age, under treatment for drug dependence (CC 31) but with no other recorded illness. His predicted cost is \$2,540, computed as the sum of \$1,428 for the demographic part (the same for all males between ages 65 and 69) and a \$1,122 contribution for CC 31. Consider, however, a second male, also drug-dependent, but only 30 years of age and entitled to Medicare through disability. Here, there is a \$5,392 total prediction, the sum of a \$955 demographic part (the same for any male under age 35) and \$4,437 for drug dependence. The latter number is computed by adding a \$3,315 age-interaction for a Medicare enrollee under age 65 in CC 31 to the \$1,122 basic payment for any Medicare enrollee in CC 31. The number \$3,315 is in the last column of [Table 2](#t2-hcfr-21-3-007){ref-type="table"} in the row labeled AI-31; drug problems cost, on average, \$3,315 more to treat in younger (disabled) Medicare enrollees than in the elderly.

Models
------

[Table 2](#t2-hcfr-21-3-007){ref-type="table"} shows the complete detail (summary statistics and all coefficients for all variables) for the three DCG/HCC models. The models are distinguished in several ways by: (1) which CCs are excluded, (2) which coefficients are constrained, (3) which demographic variables and demographic-medical interactions are included, and (4) what the model coefficients are. We discuss each of these in turn.

Exclusions, which result in coefficients being set to zero, were made for reasons previously described. The lines for the 33 CCs that are excluded from all three models are omitted from [Table 2](#t2-hcfr-21-3-007){ref-type="table"}. Exclusions used in specific models appear in [Table 2](#t2-hcfr-21-3-007){ref-type="table"} as omitted coefficients (†). The private model has no model-specific exclusions, Medicaid has one (CC3 central nervous system infections) and Medicare has 16, most of them related to maternity, neonatal and pediatric conditions that are extremely rare in Medicare\'s predominantly elderly population.

We indicate coefficients that are constrained to be equal by connecting them with a brace. For example, because only 165 people were classified in the 4 mental retardation categories (CCs 36 through 39) in the private model, these 4 coefficients are constrained to a common value of \$2,544. The three models differ in the number of constraints imposed across sets of CC coefficients, with the private model employing the most (five) and the Medicare model, the least (one).

A third difference is in the variables included in addition to the age/sex and CC predictors that characterize prospective DCG/HCC models. The Medicaid model has the most: including eligibility categories, missing-months variables, and 31 coefficients for selected age-medical interactions (labeled as AI-2, AI-15, and so on, where the AI number indicates an associated condition category). The private model includes 9 AI variables and the Medicare model, 6. The AI coefficients shown at the end of [Table 2](#t2-hcfr-21-3-007){ref-type="table"} are the increments (decrements, for negative numbers) to the basic CC payments for a younger person with those particular medical problems. "Younger" means under age 65 in Medicare and under age 18 in the other two populations.

Finally, the models differ in the values of their coefficients. A striking feature of [Table 2](#t2-hcfr-21-3-007){ref-type="table"} is the similarity between the CC coefficients in Medicare and Medicaid, estimated to within 20-30 percent for about one-half of the categories; also, for any particular CC, the larger coefficient is about equally likely to be found in either model. Thus, even though average costs are much higher in Medicare than in Medicaid, the incremental costs of treating particular conditions do not differ systematically. Although one source of higher expected costs next year in Medicare is larger age/sex coefficients, the more important explanation is greater disease prevalence. For example, 1.3 percent of the Medicare population has metastatic cancer (CC 5) but only 0.2 percent of the Medicaid population; for chronic complications of diabetes (CC 13), the rates are 1.6 percent versus 0.2 percent; for congestive heart failure (CC 48), 9.8 percent versus 1.1 percent; for acute myocardial infarction (CC 50), 4.2 percent versus only 8 in 10,000.

Medicaid and Medicare coefficients, although similar to each other, are almost always much smaller than coefficients in the private model. Typically, they are not even one-half as large as the private model coefficients. For only a handful of CCs, the Medicaid coefficient exceeds the private model coefficient: CC 32---depression and other moderate-cost mental illness; the four mental retardation CCs---36 through 39; CC 69---pleural effusion/pneumothorax; and CC 72---high-cost eye disorders. In only one instance, CC 79---nephritis, is the Medicare coefficient greater than the private one. We have no explanation for this unusual finding. It is encouraging that the private and Medicaid models are similar in terms of the age-interacted coefficients estimated for the pediatric conditions. Of the eight AI parameters present in both models, seven are of the same sign. Most of the pediatric coefficients, which were identified in the development samples, remain highly significant in these full-data re-estimated models.

In considering the plausibility of particular model coefficients, we note that each coefficient for a CC reflects the increment to expected costs that is independently associated with having the condition. An HIV-positive male\'s prediction, for example, is the sum of the CC 1 coefficient, all coefficients associated with his other medical problems, and any relevant demographic coefficients. If this male has multiple medical problems, his predicted total costs will be much larger than the coefficient for CC 1 alone. This feature is an important strength of the DCG/HCC multiple-condition model structure (in contrast to single-condition models, such as PIP-DCG), because, in fact, people who are HIV-positive differ widely in the range of medical problems they experience and how expensive they are to treat. This model does not simply pay more for HIV but rather establishes appropriately different payment amounts within the community of people living with HIV by recognizing comorbid conditions.

Measuring Model Performance
---------------------------

Because implementing a risk-adjustment model has serious consequences, we must understand how well the models work. The one universally reported, single-number summary performance measure for risk-adjustment payment models is the R^2^, or the proportion of variance in costs that the model explains. For reference, demographic payment models in private and Medicare populations have R^2^ values of less than 2 percent, and the R^2^ for a demographic/eligibility model in our Medicaid data is 7 percent ([@b9-hcfr-21-3-007]; [@b3-hcfr-21-3-007]; [@b15-hcfr-21-3-007]).

Our Medicaid model has the highest explanatory power, with a validated R^2^ of more than 20 percent, compared with 8 to 9 percent in the other two populations (refer to the fifth row of [Table 2](#t2-hcfr-21-3-007){ref-type="table"}). The better fit in Medicaid is attributable to several factors. For one, the distribution of the outcome variable, cost, has a less extreme upper tail (virtually no million-dollar cases) in Medicaid. Additionally, many people with Medicaid coverage are eligible for medical reasons (such as pregnancy or disability), and expenditures within medically defined groups are more predictable than among populations with many non-users ([@b14-hcfr-21-3-007]). Medicaid eligibility categories also distinguish groups (such as children in poor families) that have predictably lower medical costs because they are basically healthy. Finally, the "months out" variables capture the higher expected costs of recent entrants, an important factor in a system with sporadic entitlement.

All three prospective DCG/HCC models rely upon age and sex in addition to diagnostic information, and costs in these populations do differ substantially by age. For example, in the Medicaid and private samples, annual costs are each about \$3,500 more for males age 60 than for females age 5; in Medicare, there is a similar difference in annual costs for males age 90 versus females age 65. However, after accounting for differences in the prevalence of medical problems, the demographic coefficients in our models differentiate less. (The disease-adjusted differences are about \$1,400 for males age 60 than for females age 5 among the privately insured, about \$500 for a similar demographic difference in Medicaid, and \$2,000 for males age 90 versus females age 65 in Medicare.) Although age and sex coefficients remain highly statistically significant in each model, information about the presence of serious, chronic disease groups, such as diabetes and renal insufficiency, is far more useful for predicting costs.

Average Costs for Important Subgroups
-------------------------------------

Although R^2^ values are always reported, other ways of examining model performance may be more useful in assessing the value of a payment model ([@b4-hcfr-21-3-007]). We use some of these to examine the private DCG/HCC model\'s performance in a fourth, entirely new data set (a State employee health insurance plan). The methodology is to compare predicted versus actual year-2 average costs within significant subgroups. A predictive ratio (PR) for a model applied to a subgroup of people is formed by dividing the model-predicted costs for the group by their actual costs. Thus, for example, when an age/sex model is used to predict costs for a group of sick people, the PR is likely to be much less than 1.00. Alternatively, when people are identified retrospectively as a group whose costs turned out to be very low, PRs for any prospective model will be much larger than 1.00. Prospective models should never predict zero costs, because no one has zero expected future health care costs.

[Figure 3](#f3-hcfr-21-3-007){ref-type="fig"} shows PRs for several clinically defined groups of people in the State data, as predicted by the private DCG/HCC model and by an age/sex model. The medical condition groups were defined by an outside panel convened by HCFA, and membership in each group is contingent upon the presence (during year 1) of at least one panel-specified ICD-9-CM code. Although the age/sex prediction is never more than one-half the actual costs for any of these groups (all PRs are 0.50 or less), the DCG prediction is commonly between 0.95 and 1.05. The DCG model underpredicts most seriously in arthritis, where nearly 4,000 people predicted to cost around \$4,300 actually cost nearly \$5,800 (PR = 0.74). This is because the panel-identified arthritis subgroup includes anyone with any arthritis code regardless of its specificity, but the DCG model identifies only a smaller, sicker subgroup. The model does pay \$2,357 for the presence of a well-defined, systemic rheumatoid disease, such as rheumatoid arthritis (ICD-9-CM 714); however, it does not add dollars for vague codes, such as ICD-9-CM 713 (other arthropathy, joint disorders, derangements, joint pain/stiffness). When a model excludes payment for vague codes associated with real costs, it becomes less accurate; in particular, this model underpays for people with low-level or non-specific joint disorders, even though these disorders can result in significant disability.

In another illustration of the predictive value of DCG/HCC models, we divide the private validation sample into 18 groups based on predicted cost levels specified by the DCG/HCC model. The healthiest group, with predicted costs between \$250 and \$500, contains 21,650 people, or 11.3 percent of the population. (The model does not predict costs of less than \$250 for anyone.) The next group, with predicted costs of at least \$500 but less than \$750, contains another 21.6 percent of people. At the other end of the spectrum, the model predicts costs of \$5,000 or more for 5.6 percent of people; among these, just 74 (4/100 of 1 percent) fall into our highest cost prediction group (\$40,000 and over). Within each group, we calculate mean actual costs, as well as the means for DCG/HCC-predicted costs and age/sex predicted costs. At the high end, for those with predicted costs over \$5,000, the DCG/HCC-predicted amounts track actual costs quite well (meaning that PRs within these groups are not far from 1.00), while the age/sex predicted costs plateau at about \$3,300. [Figure 4](#f4-hcfr-21-3-007){ref-type="fig"}, in which average actual costs, age-sex predicted costs, and DCG-predicted costs are plotted for people in each of these 18 prediction groups, illustrates these points. The data for [Figure 4](#f4-hcfr-21-3-007){ref-type="fig"} are in [Table 3](#t3-hcfr-21-3-007){ref-type="table"}.

In summary, the private model, which was built on a large national data set, predicts costs well within a new population of State employees. It not only distinguishes groups of high- and low-cost individuals but also even identifies a high-cost tail, with small numbers of very expensive people.

The Medicaid and Medicare DCG/HCC models work similarly well (and demographic-only models, similarly poorly) in analogous comparisons of actual and predicted costs in out-of-sample validation data sets ([@b3-hcfr-21-3-007]; [@b15-hcfr-21-3-007]).

Conclusion
==========

We have extracted disease profiles of individual patients and groups of patients from the kinds of administrative records that many providers have been supplying to health care payers for years. Until now, few plans have used these data to construct a solid "information backbone" for managing care. The unified, multiple-condition DCG modeling framework characterizes individual health status and the disease burden of populations, as well as predicting future levels of resource need. When comparing physicians\' practices, patient profiles can be aggregated to describe the various mixes of medical problems that providers handle, at the same time that the model\'s predictions can help establish fair (risk-adjusted) resource allocations.

Although the original purpose of these models was to enable health care purchasers, such as HCFA, to identify an efficient capitation price, the models actually provide detailed information on the prevalence of disease. Such information helps explain why some providers and plans use more-than-average resources. The DCG/HCC health profiles and the model predictions can be used together to routinely identify patients who are likely to be very costly and to find the particular medical problems that contribute to this expectation. Such information is invaluable for identifying opportunities for selecting, implementing, and evaluating the effectiveness of disease management programs.
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###### Age, Sex, Hospital Experience, and Total Health Care Costs in Three Populations[^1^](#tfn1-hcfr-21-3-007){ref-type="table-fn"}

  Characteristic or Statistic                   Private     Medicaid    Medicare
  --------------------------------------------- ----------- ----------- -----------
  Number                                        1,379,970   1,103,367   1,360,626
  Prediction Year                               1993        1992        1992
  **Percent by Age**                                                    
  0-17 Years                                    26.7        51.4        0.0
  18-44 Years                                   44.9        40.0        3.2
  45-64 Years                                   28.4        8.7         5.8
  65 Years or Over                              0.0         0.0         91.0
  **Percent Female by Age**                                             
  0-17 Years                                    51.3        50.9        0.0
  18-44 Years                                   44.9        29.4        36.1
  45-64 Years                                   46.6        40.0        39.4
  65 Years or Over                              ---         ---         60.7
  **Total Prediction-Year Costs**                                       
  Mean                                          \$1,592     \$1,430     \$3,778
  Standard Deviation                            8,236       5,407       10,523
  Coefficient of Variation                      517         378         279
  Median                                        85          121         516
  99th Percentile                               25,472      23,208      57,423
  Maximum                                       2,412,707   1,253,880   1,533,060
  Percent with Zero Prediction-Year Costs       42.9        32.3        16.1
  Percent Hospitalized in the Prediction Year   4.8         8.4         21.2

For people with at least 1 month of eligibility in each of the baseline and prediction years.

SOURCE: ([@b3-hcfr-21-3-007]; [@b15-hcfr-21-3-007].)

###### Statistics for Private, Medicaid, and Medicare Prospective Payment Models

  Statistic or Variable                                                                  Private                                         Medicaid                                                          Medicare                                                                                                                                                                                                                                        
  -------------------------------------------------------------------------------------- ----------------------------------------------- ----------------------------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- -------
  Number of Observations                                                                 1,379,023                                       1,103,367                                                         1,360,626                                                                                                                                                                                                                                       
  Prediction Year Mean Total Costs                                                       1,593                                           1,430                                                             3,778                                                                                                                                                                                                                                           
  Number of Model Parameters                                                             102                                             136                                                               96                                                                                                                                                                                                                                              
  *R*^2^ × 100                                                                           9.4                                             21.1                                                              8.8                                                                                                                                                                                                                                             
  Validated *R*^2^ × 100                                                                 9.1                                             23.1                                                              8.5                                                                                                                                                                                                                                             
  Standard Error                                                                         7,843                                           4,802                                                             9,963                                                                                                                                                                                                                                           
  **Age/Sex Groups**                                                                     Model Coefficients                                                                                                                                                                                                                                                                                                                                                
  **Female**                                                                                                                                                                                                                                                                                                                                                                                                                                               
   0-5 Years                                                                             295                                             -6                                                                                                                1,324                                                                                                                                                                                           
   6-12 Years                                                                            241                                             0                                                                 1,324                                                                                                                                                                                                                                           
   13-17 Years                                                                           479                                             270                                                               1,324                                                                                                                                                                                                                                           
   18-24 Years                                                                           613                                             560                                                               1,324                                                                                                                                                                                                                                           
   25-34 Years                                                                           1,187                                           337                                                               1,324                                                                                                                                                                                                                                           
   35-44 Years                                                                           1,120                                           345                                                               1,155                                                                                                                                                                                                                                           
   45-54 Years                                                                           1,401                                           446                                                               1,202                                                                                                                                                                                                                                           
   55-64 Years                                                                           1,730                                           537                                                               1,698                                                                                                                                                                                                                                           
   65-69 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     1,042                                                                                                                                                                                                                                           
   70-74 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     1,318                                                                                                                                                                                                                                           
   75-79 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     1,675                                                                                                                                                                                                                                           
   80-84 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     1,962                                                                                                                                                                                                                                           
   85-89 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     2,161                                                                                                                                                                                                                                           
   90-94 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     2,258                                                                                                                                                                                                                                           
   95 Years or Over                                                                      [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     1,897                                                                                                                                                                                                                                           
  **Male**                                                                                                                                                                                                                                                                                                                                                                                                                                                 
   0-5 Years                                                                             312                                             87                                                                                                                955                                                                                                                                                                                             
   6-12 Years                                                                            271                                             113                                                               955                                                                                                                                                                                                                                             
   13-17 Years                                                                           473                                             334                                                               955                                                                                                                                                                                                                                             
   18-24 Years                                                                           370                                             86                                                                955                                                                                                                                                                                                                                             
   25-34 Years                                                                           574                                             132                                                               955                                                                                                                                                                                                                                             
   35-44 Years                                                                           778                                             392                                                               904                                                                                                                                                                                                                                             
   45-54 Years                                                                           1,218                                           571                                                               887                                                                                                                                                                                                                                             
   55-64 Years                                                                           2,126                                           526                                                               1,403                                                                                                                                                                                                                                           
   65-69 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     1,428                                                                                                                                                                                                                                           
   70-74 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     1,743                                                                                                                                                                                                                                           
   75-79 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     2,215                                                                                                                                                                                                                                           
   80-84 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     2,426                                                                                                                                                                                                                                           
   85-89 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     2,725                                                                                                                                                                                                                                           
   90-94 Years                                                                           [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     3,027                                                                                                                                                                                                                                           
   95 Years or Over                                                                      [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                     2,980                                                                                                                                                                                                                                           
  **Medicaid Eligibility Categories**                                                                                                                                                                                                                                                                                                                                                                                                                      
  Blind/Disabled                                                                         [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   1,449                                                             [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                   
  Other Medical                                                                          [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   429                                                               [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                   
  Poverty-Related                                                                        [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   476                                                               [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                   
  Pregnant Women                                                                         [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   96                                                                [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                   
  Other                                                                                  [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   -263                                                              [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                   
  **Medicaid Amount Added per Missing Base Year Month for**                                                                                                                                                                                                                                                                                                                                                                                                
  Blind/Disabled                                                                         [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   179                                                               [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                   
  Other Medical                                                                          [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   71                                                                [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                   
  Poverty-Related                                                                        [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   56                                                                [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                   
  Pregnant Women                                                                         [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   296                                                               [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                   
  Other                                                                                  [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}   100                                                               [‡](#tfn4-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                   
  **Condition Categories**[^2^](#tfn6-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                                  
  1                                                                                      Infection1                                      HIV/AIDS                                                          22,580                                          5,284                                           1,076                                                                                                                                           
  2                                                                                      Infection2                                      Septicemia (Blood Poisoning)/Shock                                8,677                                           3,663                                           3,253                                                                                                                                           
  3                                                                                      Infection3                                      Central Nervous System Infections                                 4,658                                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   760                                                                                                                                             
  5                                                                                      Neoplasm1                                       Metastatic Cancer                                                 21,884                                          6,331                                           6,185                                                                                                                                           
  6                                                                                      Neoplasm2                                       High-Cost Cancer                                                  11,967                                          3,278                                           3,905                                                                                                                                           
  7                                                                                      Neoplasm3                                       Moderate-Cost Cancer                                              5,863                                           1,288                                           2,128                                                                                                                                           
  8                                                                                      Neoplasm4                                       Lower Cost Cancers/Tumors                                         2,372                                           550                                             873                                                                                                                                             
  13                                                                                     Diabetes1                                       Diabetes with Chronic Complications                               7,726                                           3,686                                           3,582                                                                                                                                           
  14                                                                                     Diabetes2                                       Diabetes with Acute Complications/Non-Proliferative Retinopathy   3,806                                           2,392                                           2,396                                                                                                                                           
  15                                                                                     Diabetes3                                       Diabetes with No or Unspecified Complications                     1,961                                           369                                             1,147                                                                                                                                           
  16                                                                                     Metabolic1                                      Protein-Calorie Malnutrition                                      13,639                                          5,012                                           3,594                                                                                                                                           
  19                                                                                     Liver                                           Liver Disease                                                     5,700                                           4,007                                           3,028                                                                                                                                           
  20                                                                                     GI1                                             High-Cost Chronic Gastrointestinal Disorders                      4,312                                           2,944                                           1,336                                                                                                                                           
  21                                                                                     GI2                                             High-Cost Acute Gastrointestinal Disorders                        2,087                                           1,213                                           1,329                                                                                                                                           
  22                                                                                     GI3                                             Moderate-Cost Gastrointestinal Disorders                          1,432                                           748                                             730                                                                                                                                             
  24                                                                                     MSK1                                            Bone/Joint Infections/Necrosis                                    3,653                                           3,563                                           2,070                                                                                                                                           
  25                                                                                     MSK2                                            Rheumatoid Arthritis and Connective Tissue Disease                2,380                                           870                                             1,218                                                                                                                                           
  27                                                                                     Blood1                                          Aplastic and Acquired Hemolytic Anemias                           9,801                                           6,562                                           4,035                                                                                                                                           
  28                                                                                     Blood2                                          Blood/Immune Disorders                                            4,248                                           3,637                                           709                                                                                                                                             
  30                                                                                     Dementia                                        Dementia                                                          4,822                                           1,324                                           438                                                                                                                                             
  31                                                                                     Mental1                                         Drug/Alcohol Dependence/Psychoses                                 3,568                                           2,223                                           1,122                                                                                                                                           
  32                                                                                     Mental2                                         Psychosis and Other Higher Cost Mental Disorders                  3,092                                           3,599                                           1,288                                                                                                                                           
  33                                                                                     Mental3                                         Depression and Other Moderate-Cost Mental Disorders               2,171                                           834                                             540                                                                                                                                             
  34                                                                                     Mental4                                         Anxiety Disorders                                                 1,788                                           771                                             511                                                                                                                                             
  36                                                                                     MR1                                             Profound Mental Retardation                                                                                       2,544                                           22,370                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                   
  37                                                                                     MR2                                             Severe Mental Retardation                                         2,544                                           16,064                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  38                                                                                     MR3                                             Moderate Mental Retardation                                       2,544                                           11,677                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  39                                                                                     MR4                                             Mild/Unspecified Mental Retardation                               2,544                                           5,508                                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  40                                                                                     Neuro1                                          Quadriplegia                                                                                                      12,506                                          5,632                                           5,686                                                                                           
  41                                                                                     Neuro2                                          Paraplegia                                                        12,506                                          3,467                                           5,788                                                                                                                                           
  42                                                                                     Neuro3                                          Higher Cost Neurological Disorders                                3,939                                           1,452                                           1,851                                                                                                                                           
  43                                                                                     Neuro4                                          Moderate-Cost Neurological Disorders                              1,936                                           1,037                                           1,261                                                                                                                                           
  45                                                                                     Arrest1                                         Respirator Dependence/Tracheostomy Status                         41,465                                          24,247                                          9,117                                                                                                                                           
  46                                                                                     Arrest2                                         Respiratory Arrest                                                13,396                                          3,538                                           8,087                                                                                                                                           
  47                                                                                     Arrest3                                         Cardio-Respiratory Failure and Shock                              3,416                                           2,673                                           2,809                                                                                                                                           
  48                                                                                     Hrt_CHF                                         Congestive Heart Failure                                          5,114                                           2,714                                           2,069                                                                                                                                           
  49                                                                                     Hrt_ARR                                         Heart Arrhythmia                                                  1,872                                           928                                             670                                                                                                                                             
  50                                                                                     Hrt_AMI                                         Acute Myocardial Infarction                                       4,723                                           3,792                                           1,778                                                                                                                                           
  51                                                                                     Hrt_CAD1                                        Other Acute Ischemic Heart Disease                                3,442                                           1,639                                           1,807                                                                                                                                           
  52                                                                                     Hrt_CAD2                                        Chronic Ischemic Heart Disease                                    2,871                                           511                                             883                                                                                                                                             
  53                                                                                     Hrt_VHD                                         Valvular and Rheumatic Heart Disease                              1,128                                           741                                             938                                                                                                                                             
  54                                                                                     Hrt_HTN                                         Hypertensive Heart Disease                                        1,346                                           436                                             347                                                                                                                                             
  57                                                                                     HTN                                             Hypertension (High Blood Pressure)                                915                                             312                                             216                                                                                                                                             
  58                                                                                     Stroke1                                         Higher Cost Cerebrovascular Disease                               3,902                                           1,523                                           1,919                                                                                                                                           
  59                                                                                     Stroke2                                         Lower Cost Cerebrovascular Disease                                1,795                                           645                                             835                                                                                                                                             
  60                                                                                     Vascular1                                       High-Cost Vascular Disease                                        2,486                                           1,420                                           1,268                                                                                                                                           
  61                                                                                     Vascular2                                       Thromboembolic Vascular Disease                                   2,505                                           2,316                                           1,429                                                                                                                                           
  64                                                                                     Lung1                                           Chronic Obstructive Pulmonary Disease                             2,633                                           1,034                                           1,669                                                                                                                                           
  65                                                                                     Lung2                                           Higher Cost Pneumonia                                             8,092                                           3,455                                           4,037                                                                                                                                           
  66                                                                                     Lung3                                           Moderate-Cost Pneumonia                                           3,411                                           492                                             1,229                                                                                                                                           
  68                                                                                     Lung5                                           Pulmonary Fibrosis and Other Chronic Lung Disorders               3,254                                           936                                             829                                                                                                                                             
  69                                                                                     Lung6                                           Pleural Effusion/Pneumothorax                                     2,239                                           2,506                                           1,456                                                                                                                                           
  70                                                                                     Lung7                                           Asthma                                                            1,513                                           409                                             624                                                                                                                                             
  72                                                                                     Eye1                                            Higher Cost Eye Disorders                                         783                                             1,110                                           242                                                                                                                                             
  74                                                                                     ENT1                                            Higher Cost Ear, Nose, and Throat Disorders                       685                                             620                                             147                                                                                                                                             
  76                                                                                     Urinary1                                        Dialysis Status                                                   37,287                                          3,693                                           6,821                                                                                                                                           
  77                                                                                     Urinary2                                        Kidney Transplant Status                                          10,333                                          215                                             6,468                                                                                                                                           
  78                                                                                     Urinary3                                        Renal Failure                                                     17,834                                          5,742                                           3,107                                                                                                                                           
  79                                                                                     Urinary4                                        Nephritis                                                         1,050                                           1,026                                           1,627                                                                                                                                           
  81                                                                                     Genital1                                        Female Infertility                                                2,242                                           455                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  82                                                                                     Genital2                                        Moderate-Cost Genital Disorders                                   889                                             345                                             89                                                                                                                                              
  84                                                                                     Preg1                                           Ectopic Pregnancy                                                 1,957                                           951                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  85                                                                                     Preg2                                           Miscarriage/Abortion                                              1,892                                           1,064                                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  86                                                                                     Preg3                                           High-Cost Completed Pregnancy                                                                                     572                                                                                             262                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   
  87                                                                                     Preg4                                           Moderate-Cost Completed Pregnancy                                 572                                             262                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  88                                                                                     Preg5                                           Normal Delivery                                                   572                                             262                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  89                                                                                     Preg6                                           Higher Cost Pregnancy without Completion                                                                          4,060                                                                                           1,674                                                                                           1,634
  90                                                                                     Preg7                                           Lower Cost Pregnancy without Completion                           4,060                                           1,674                                           1,634                                                                                                                                           
  91                                                                                     Skin1                                           Chronic Ulcer of Skin                                             3,756                                           2,468                                           2,473                                                                                                                                           
  93                                                                                     Injury1                                         Vertebral Fractures and Spinal Cord Injuries                      2,992                                           546                                             1,289                                                                                                                                           
  94                                                                                     Injury2                                         Hip Fracture/Dislocation                                          1,280                                           463                                             993                                                                                                                                             
  95                                                                                     Injury3                                         Head Injuries                                                     763                                             95                                              428                                                                                                                                             
  96                                                                                     Injury4                                         Drug Poisoning, Internal Injury, Traumatic Amputation, Burn       1,588                                           932                                             1,256                                                                                                                                           
  98                                                                                     Complic                                         Complications of Care                                             2,369                                           1,380                                           798                                                                                                                                             
  101                                                                                    Peds                                            Very-High-Cost Pediatric Disorders                                5,901                                           2,067                                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  102                                                                                    Cong1                                           Higher Cost Congenital/Pediatric Disorders                        4,948                                           710                                             2,081                                                                                                                                           
  103                                                                                    Cong2                                           Moderate-Cost Congenital Disorder                                 1,603                                           355                                             532                                                                                                                                             
  104                                                                                    Cong3                                           Lower Cost Congenital Disorder                                    829                                             334                                             348                                                                                                                                             
  105                                                                                    Baby1                                           Extremely-Low-Birthweight Neonates                                                                                13,238                                          1,852                                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                   
  106                                                                                    Baby2                                           Very-Low-Birthweight Neonates                                     13,238                                          1,163                                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  107                                                                                    Baby3                                           Serious Perinatal Problem Affecting Newborn                       1,010                                           323                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  108                                                                                    Baby4                                           Other Perinatal Problem Affecting Newborn                         145                                                                                             78                                              [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                   
  109                                                                                    Baby5                                           Normal, Single Birth                                              332                                             78                                              [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  110                                                                                    Transplant1                                     Heart, Lung, Liver Transplant Status                              26,576                                          5,312                                           3,552                                                                                                                                           
  112                                                                                    Openings                                        Artificial Opening Status/Attention                               5,588                                           4,317                                           2,696                                                                                                                                           
  **Age-Interacted Condition Category**[^3^](#tfn7-hcfr-21-3-007){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                     
  AI-1                                                                                   Infection1                                      HIV/AIDS                                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   8,735                                                                                                                                           
  AI-2                                                                                   Infection2                                      Septicemia (Blood Poisoning)/Shock                                [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -2,615                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-15                                                                                  Diabetes3                                       Diabetes with No or Unspecified Complications                     [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -157                                            [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-20                                                                                  GI1                                             High-Cost Chronic Gastrointestional Disorders                     [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -924                                            4,241                                                                                                                                           
  AI-21                                                                                  GI2                                             High-Cost Acute Gastrointestional Disorders                       1,406                                           -313                                            [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-22                                                                                  GI3                                             Moderate-Cost Gastrointestinal Disorders                          -1,044                                          -460                                            [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-24                                                                                  MSK1                                            Bone/Joint Infections/Necrosis                                    [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -3,047                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-25                                                                                  MSK2                                            Rheumatoid Arthritis and Connective Tissue Disease                [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -812                                            [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-27                                                                                  Blood1                                          Aplastic and Acquired Hemolytic Anemias                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -4,872                                          3,365                                                                                                                                           
  AI-28                                                                                  Blood2                                          Blood/Immune Disorders                                            [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -2,108                                          2,019                                                                                                                                           
  AI-30                                                                                  Dementia                                        Dementia                                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   373                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-31                                                                                  Mental1                                         Drug/Alcohol Dependence/Psychoses                                 [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -1,135                                          3,315                                                                                                                                           
  AI-32                                                                                  Mental2                                         Psychosis and Other Higher Cost Mental Disorders                  346                                             3,842                                           1,204                                                                                                                                           
  AI-33                                                                                  Mental3                                         Depression and Other Moderate Cost Mental Disorders               [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   1,876                                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-36                                                                                  MR1                                             Profound Mental Retardation                                       [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -4,752                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-37                                                                                  MR2                                             Severe Mental Retardation                                         [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -6,924                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-38                                                                                  MR3                                             Moderate Mental Retardation                                       [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -5,056                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-39                                                                                  MR4                                             Mild/Unspecified Mental Retardation                               [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -1,717                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-42                                                                                  Neuro3                                          Higher Cost Neurological Disorders                                [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   1,377                                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-43                                                                                  Neuro4                                          Moderate-Cost Neurological Disorders                              -929                                            -224                                            [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-58                                                                                  Stroke1                                         Higher Cost Cerebrovascular Disease                               [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -1,450                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-59                                                                                  Stroke2                                         Lower Cost Cerebrovascular Disease                                [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   1,417                                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-64                                                                                  Lung1                                           Chronic Obstructive Pulmony Disease                               -1,904                                          -734                                            [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-65                                                                                  Lung2                                           Higher Cost Pneumonia                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   365                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-70                                                                                  Lung7                                           Asthma                                                            -688                                            [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-82                                                                                  Genital2                                        Moderate-Cost Genital Disorders                                   348                                             364                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-88                                                                                  Preg5                                           Normal Delivery                                                   [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   395                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-90                                                                                  Preg7                                           Lower Cost Pregnancy without Completion                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   472                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-94                                                                                  Injury2                                         Hip Fracture/Dislocation                                          [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   245                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-96                                                                                  Injury4                                         Drug Poisoning, Internal Injury, Traumatic Amputation, Burn       -1,336                                          -554                                            [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-98                                                                                  Complic                                         Complications of Care                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   -710                                            [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-102                                                                                 Cong1                                           Higher Cost Congenital/Pediatric Disorders                        [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}   2,757                                           [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   
  AI-103                                                                                 Cong2                                           Moderate-Cost Congenital Disorder                                 1,383                                           911                                             [†](#tfn3-hcfr-21-3-007){ref-type="table-fn"}                                                                                                   

Indicates a coefficient constrained to zero.

Indicates a variable that is not relevant for a particular model.

The Medicare model combines age/sex categories 0-34 years for each of females and males.

Lines for CCs that are zeroed out in all three prospective models are not listed in this table.

Values are increments or decrements for younger persons in this CC (under 18 for private and Medicaid; under 65 for Medicare) after receiving the basic CC payment coefficient listed in this table.

NOTES: Coefficients joined by a brace are constrained to be the same. CC is condition category. HIV is human immunodeficiency virus. AIDS is acquired immunodeficiency syndrome.

SOURCE: ([@b3-hcfr-21-3-007]; [@b15-hcfr-21-3-007].)

###### Means of Actual and Predicted Cost for the Private Validation Sample, by DCG-Prediction Group

  Predicted Cost Group[^1^](#tfn10-hcfr-21-3-007){ref-type="table-fn"}   Actual Costs   DCG-Predicted Costs   Age/Sex Predicted Costs   Counts
  ---------------------------------------------------------------------- -------------- --------------------- ------------------------- --------
  Less than \$250                                                        ---            ---                   ---                       0
  250                                                                    \$510          \$417                 \$570                     21,650
  500                                                                    672            620                   855                       41,384
  750                                                                    931            867                   1,262                     22,649
  1,000                                                                  1,391          1,347                 1,915                     28,782
  1,500                                                                  1,707          1,714                 2,335                     30,786
  2,000                                                                  2,295          2,242                 3,140                     16,100
  2,500                                                                  2,510          2,779                 3,195                     5,828
  3,000                                                                  3,373          3,406                 3,332                     9,086
  4,000                                                                  3,993          4,451                 2,695                     4,944
  5,000                                                                  4,734          5,485                 2,859                     3,474
  6,000                                                                  6,478          6,624                 2,951                     2,747
  7,500                                                                  8,025          8,557                 3,012                     1,980
  10,000                                                                 11,415         11,939                3,006                     1,314
  15,000                                                                 15,741         17,042                3,217                     441
  20,000                                                                 20,426         22,377                2,853                     257
  25,000                                                                 31,804         27,181                2,929                     227
  30,000                                                                 40,559         34,087                3,010                     154
  40,000                                                                 61,380         52,026                2,926                     74

Each predicted cost group contains all people whose DCG-predicted dollar cost are at least this great but less than the next higher number.

NOTES: DCG is Diagnostic Cost Group. *n* = 191,877.

SOURCE: ([@b4-hcfr-21-3-007].)

###### Condition Category (CC) Numbers, Long Names, Short Names, and Hierarchies

  CC Number   CC Long Name                                                       CC Short Name   Dominated CCs
  ----------- ------------------------------------------------------------------ --------------- ----------------------------------------
  1           HIV/AIDS                                                           Infection1      None
  2           Septicemia (Blood Poisoning)/Shock                                 Infection2      None
  3           Central Nervous System Infections                                  Infection3      None
  4           Other Infectious Disease                                           Infection4      None
  5           Metastatic Cancer                                                  Neoplasm1       6, 7, 8, 9, 10, 11, 12
  6           High-Cost Cancer                                                   Neoplasm2       7, 8, 9, 10, 11, 12
  7           Moderate-Cost Cancer                                               Neoplasm3       8, 9, 10, 11, 12
  8           Lower Cost Cancers/Tumors                                          Neoplasm4       9, 10, 11, 12
  9           Carcinoma in Situ                                                  Neoplasm5       10, 11, 12
  10          Uncertain Neoplasm                                                 Neoplasm6       11, 12
  11          Skin Cancer, Except Melanoma                                       Neoplasm7       12
  12          Benign Neoplasm                                                    Neoplasm8       None
  13          Diabetes with Chronic Complications                                Diabetes1       14, 15
  14          Diabetes with Acute Complications/Non-Proliferative Retinopathy    Diabetes2       15
  15          Diabetes with No or Unspecified Complications                      Diabetes3       None
  16          Protein-Calorie Malnutrition                                       Metabolic1      None
  17          Moderate-Cost Endocrine/Metabolic/Fluid-Electrolyte Disorders      Metabolic2      None
  18          Other Endocrine, Metabolic, Nutritional Disorders                  Metabolic3      None
  19          Liver Disease                                                      Liver           None
  20          High-Cost Chronic Gastrointestinal Disorders                       GI1             22, 23
  21          High-Cost Acute Gastrointestinal Disorders                         GI2             22, 23
  22          Moderate-Cost Gastrointestinal Disorders                           GI3             23
  23          Lower Cost Gastrointestinal Disorders                              GI4             None
  24          Bone/Joint Infections/Necrosis                                     MSK1            None
  25          Rheumatoid Arthritis and Connective Tissue Disease                 MSK2            26
  26          Other Musculoskeletal and Connective Tissue Disorders              MSK3            None
  27          Aplastic and Acquired Hemolytic Anemias                            Blood1          28, 29
  28          Blood/Immune Disorders                                             Blood2          29
  29          Iron Deficiency and Other/Unspecified Anemias                      Blood3          None
  30          Dementia                                                           Dementia        None
  31          Drug/Alcohol Dependence/Psychoses                                  Mental1         32, 33, 34, 35
  32          Psychosis and Other Higher Cost Mental Disorders                   Mental2         33, 34, 35
  33          Depression and Other Moderate-Cost Mental Disorders                Mental3         34, 35
  34          Anxiety Disorders                                                  Mental4         35
  35          Lower Cost Mental Disorders/Substance Misuse                       Mental5         None
  36          Profound Mental Retardation                                        MR1             37, 38, 39
  37          Severe Mental Retardation                                          MR2             38, 39
  38          Moderate Mental Retardation                                        MR3             39
  39          Mild/Unspecified Mental Retardation                                MR4             None
  40          Quadriplegia                                                       Neuro1          41, 42, 43, 44
  41          Paraplegia                                                         Neuro2          42, 43, 44
  42          Higher Cost Neurological Disorders                                 Neuro3          43, 44
  43          Moderate-Cost Neurological Disorders                               Neuro4          44
  44          Lower Cost Neurological Disorders                                  Neuro5          None
  45          Respirator Dependence/Tracheostomy Status                          Arrest1         46, 47
  46          Respiratory Arrest                                                 Arrest2         47
  47          Cardio-Respiratory Failure and Shock                               Arrest3         None
  48          Congestive Heart Failure                                           Hrt_CHF         55, 56, 57
  49          Heart Arrhythmia                                                   Hrt_ARR         55, 56, 57
  50          Acute Myocardial Infarction                                        Hrt_AMI         51, 52, 55, 56, 57
  51          Other Acute Ischemic Heart Disease                                 Hrt_CAD1        52, 55, 56, 57
  52          Chronic Ischemic Heart Disease                                     Hrt_CAD2        55, 56, 57
  53          Valvular and Rheumatic Heart Disease                               Hrt_VHD         55, 56, 57
  54          Hypertensive Heart Disease                                         Hrt_HTN         55, 56, 57
  55          Other Heart Diagnoses                                              Hrt_Misc        56
  56          Heart Rhythm and Conduction Disorders                              Hrt_Rhythm      None
  57          Hypertension (High Blood Pressure)                                 HTN             None
  58          Higher Cost Cerebrovascular Disease                                Stroke1         59
  59          Lower Cost Cerebrovascular Disease                                 Stroke2         None
  60          High-Cost Vascular Disease                                         Vascular1       62, 63
  61          Thromboembolic Vascular Disease                                    Vascular2       62, 63
  62          Atherosclerosis/Unspecified                                        Vascular3       None
  63          Other Circulatory Disease                                          Vascular4       None
  64          Chronic Obstructive Pulmonary Disease                              Lung1           70, 71
  65          Higher Cost Pneumonia                                              Lung2           66, 67, 69, 71
  66          Moderate-Cost Pneumonia                                            Lung3           67, 69, 71
  67          Lower Cost Pneumonia                                               Lung4           71
  68          Pulmonary Fibrosis and Other Chronic Lung Disorders                Lung5           70, 71
  69          Pleural Effusion/Pneumothorax                                      Lung6           71
  70          Asthma                                                             Lung7           71
  71          Other Lung Disease                                                 Lung8           None
  72          Higher Cost Eye Disorders                                          Eye1            73
  73          Lower Cost Eye Disorders                                           Eye2            None
  74          Higher Cost Ear, Nose, and Throat Disorders                        ENT1            75
  75          Lower Cost Ear, Nose, and Throat Disorders                         ENT2            None
  76          Dialysis Status                                                    Urinary1        77, 78, 79, 80
  77          Kidney Transplant Status                                           Urinary2        78, 79, 80
  78          Renal Failure                                                      Urinary3        79, 80
  79          Nephritis                                                          Urinary4        80
  80          Other Urinary System Disorders                                     Urinary5        None
  81          Female Infertility                                                 Genital1        82, 83
  82          Moderate-Cost Genital Disorders                                    Genital2        83
  83          Low-Cost Genital Disorders                                         Genital3        None
  84          Ectopic Pregnancy                                                  Preg1           85, 89, 90
  85          Miscarriage/Abortion                                               Preg2           89, 90
  86          Completed Pregnancy with Major Complications                       Preg3           87, 88, 89, 90
  87          Completed Pregnancy with Complications                             Preg4           88, 89, 90
  88          Completed Pregnancy Without Complications (Normal Delivery)        Preg5           89, 90
  89          Uncompleted Pregnancy with Complications                           Preg6           90
  90          Uncompleted Pregnancy with No or Minor Complications               Preg7           None
  91          Chronic Ulcer of Skin                                              Skin1           92
  92          Other Dermatological Disorders                                     Skin2           None
  93          Vertebral Fractures and Spinal Cord Injuries                       Injury1         97
  94          Hip Fracture/Dislocation                                           Injury2         97
  95          Head Injuries                                                      Injury3         97
  96          Drug Poisonings, Internal Injuries, Traumatic Amputations, Burns   Injury4         97
  97          Other Injuries and Poisonings                                      Injury5         None
  98          Complications of Care                                              Complic         None
  99          Major Symptoms                                                     Symptom1        None
  100         Minor Symptoms, Signs, Findings                                    Symptom2        None
  101         Very-High-Cost Pediatric Disorders                                 Peds            20, 22, 23, 28, 29, 43, 44, 68, 70, 71
  102         Higher Cost Congenital/Pediatric Disorders                         Cong1           104
  103         Moderate-Cost Congenital Disorder                                  Cong2           104
  104         Lower Cost Congenital Disorder                                     Cong3           None
  105         Extremely-Low-Birthweight Neonates                                 Baby1           106, 107, 108, 109
  106         Very-Low-Birthweight Neonates                                      Baby2           107, 108, 109
  107         Serious Perinatal Problem Affecting Newborn                        Baby3           109
  108         Other Perinatal Problems Affecting Newborn                         Baby4           109
  109         Normal, Single Birth                                               Baby5           None
  110         Heart, Lung, Liver Transplant Status                               Transplant1     None
  111         Other Organ Transplant/Replacement                                 Transplant2     None
  112         Artificial Opening Status/Attention                                Openings        None
  113         Elective/Aftercare                                                 Surgery         None
  114         Radiation Therapy                                                  Radiation       None
  115         Chemotherapy                                                       Chemo           None
  116         Rehabilitation                                                     Rehab           None
  117         Screening/Observation/Special Exams                                Screening       None
  118         History of Disease                                                 History         None

NOTES: HIV is human immunodeficiency virus. AIDS is acquired immunodeficiency syndrome.

SOURCE: ([@b3-hcfr-21-3-007].)
